We acquire, market and develop a portfolio of mature branded medicines globally

What we do

Pill icon


We acquire “mature” (i.e. post-patent expiry), established branded prescription medicines from large cap and specialty pharma.

Suitcase icon


We currently own and market a portfolio of more than 15 medicines and operate in more than 130 markets globally.

Beaker icon


We develop line extensions (new formulations or new markets) to the medicines we acquire. We also develop our own niche generic medicines in-house.

How we do it

Team icon


Our dedicated team of regulatory, artwork, technical and project management experts has vast experience in transitioning medicines seamlessly into our manufacturing and distribution networks, and working with vendors to ensure there is no disruption in supply to wholesalers, hospitals, pharmacies and ultimately – and most importantly – patients.

Line up icon

In Line

Once we have successfully transitioned an acquired medicine or launched a developed medicine, our In Line team takes over the life cycle management of the medicines, making sure we maintain the highest standard of ethical medical practice, manage our supply chain effectively and responsibly and deliver high-quality medicines to our patients.

Microscope icon

Product Development

Our chemists work with our regulatory, artwork and technical experts to make the most of the medicines we acquire, developing new formulations for new markets. They also work on developing and launching generic medicines for niche indications.

Our key therapeutic areas


Women’s Health and Endocrinology

Our key medicines include Bonviva®, Gynest®, Synacthen® and Traxidot®

Man holding wrist in pain

Neurology and Pain

Our key medicines include Anaprox®, Naprosyn®, Sinepin®, Toradol® and Welldorm®

Woman making heart shape with hands on tummy


Our key medicines include Dipentum® and Kytril®

Cancer cell


Our key medicines include Bondronat® and Kytril®

Illustration of a box 15+ Brands
Illustration of a group of people 90+ Employees
Illustration of a globe with a map marker 130+ Markets
Illustration of a box 990+ Marketing Authorisations

Our markets and offices

We partner with distribution partners to offer as wide a market coverage as possible. Our network now covers over 130 markets. We have offices in Basildon, Copenhagen, Dubai, Sydney and Vadodara.

  • Our markets
  • Map pin icon Our offices
Map of Atnahs distribution markets and offices

Our partnerships and memberships


Our specialty pharma subsidiary, Pharmanovia, focuses upon in-licensing, out-licensing and development of both medicines and medical devices in the Nordics and Europe. Learn more at www.pharmanovia.com


We are proud to be a member of EMIG, the Ethical Medicines Industry Group. Learn more at emig.org.uk

Looking to license or divest a medicine?

Or are you a CMO or distributor who wishes to partner with us?

Get in touch